3,3',4,5'-tetrahydroxystilbene has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, A; Ma, JY | 1 |
| Cho, HJ; Her, S; Jung, JI; Kang, YH; Kwon, SH; Lee, KW; Park, JH; Song, H; Yu, R | 1 |
2 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Piceatannol-3-O-β-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Topics: Adult; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Chick Embryo; Chorioallantoic Membrane; Fibrosarcoma; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Stilbenes; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A | 2019 |
Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Lung Neoplasms; Macrophages; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Neovascularization, Pathologic; Phosphorylation; STAT3 Transcription Factor; Stilbenes; Transcription Factor RelA | 2015 |